That's great, but private insurance and out of pocket accounts for almost 2x the annual drug spend that Medicare does [1]. So there's nothing stopping pharma co

That's great, but private insurance and out of pocket accounts for almost 2x the annual drug spend that Medicare does [1]. So there's nothing stopping pharma companies from shifting the costs to maintain profits. In a way, this is a cost shifting exercise from Boomers to everyone else. Without a Medicare-for-all system, Congress could still easily stop this by capping pharma company profits but I haven't even seen an attempt to do so. [1] https://www.kff.org/medicare/issue-brief/how-does-prescription-drug-spending-and-use-compare-across-large-employer-plans-medicare-part-d-and-medicaid/ https://www.kff.org/medicare/issue-brief/how-does-prescripti...